| Stereochemistry | UNKNOWN |
| Molecular Formula | C18H22N2O2S |
| Molecular Weight | 330.444 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C3=CC=CC=C13
InChI
InChIKey=QTQPVLDZQVPLGV-UHFFFAOYSA-N
InChI=1S/C18H22N2O2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)23(21,22)18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3
| Molecular Formula | C18H22N2O2S |
| Molecular Weight | 330.444 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
Sample Use Guides
Oxomemazine 0.33 mg/ml syrup.
Suitable for adults and children over 40 kg (from the age of 12 years old).
10 ml 4 times per day.
For children:
The daily dose according to a child’s weight (1ml of syrup per kg per day):
· Child between 13-20 kg (between 2-6 years old): 5ml 2-3 times per day.
· Child between 20-30 kg (between 6-10 years old): 10 ml 2-3 times per day.
· Child between 30-40 kg (between 10-12 years old): 10 ml 3-4 times a day.
Repeat if necessary minimum every 4 hours.
Due to the sedative effect of oxomemazine it is advisable to take this medication in the evening.
Route of Administration:
Oral
|
|
RACEMATE -> ENANTIOMER | |||
|
|
ENANTIOMER -> ENANTIOMER |
|
Showing 1 to 2 of 2 entries